STOCK TITAN

Saratoga Investment expands credit facility to $110M

The amendment raises the healthcare and three-largest-obligor concentration limits to 35% of Aggregate ECA Value.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Saratoga Investment Corp. (SAJ) and its wholly owned financing subsidiary, Saratoga Investment Funding II LLC, amended the Valley Credit Facility on October 8, 2026. The amendment increases available borrowings from $85.0 million to $110.0 million.

During the first two years following the closing date, SIF II may request one or more commitment increases; the amount for those requests rises from $100.0 million to $135.0 million, subject to certain terms and conditions and a customary fee. The amendment caps the Advance Rate for Unitranche Loans at 70% and raises the healthcare concentration limit from 25.0% to 35.0% of Aggregate ECA Value and the limit for loans to the three largest Obligors from 30.0% to 35.0%. It also replaces Henri Steenkamp with Christine Ramdihal in the definition of “Key Person.”

Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement Financial
The company incurred a new significant debt or off-balance-sheet obligation.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Available borrowings From $85.0 million to $110.0 million Change under the October 8, 2026 amendment
Commitment increase request amount From $100.0 million to $135.0 million SIF II may request one or more increases during the first two years following the closing date, subject to certain terms and conditions and a customary fee
Maximum Advance Rate 70% For Unitranche Loans
Healthcare concentration From 25.0% to 35.0% of Aggregate ECA Value Concentration of the Borrowing Base Value of all Collateral Loans in healthcare
Three-largest-Obligor concentration From 30.0% to 35.0% of Aggregate ECA Value Concentration of the Borrowing Base Value of Collateral Loans made to the three largest Obligors
Advance Rate financial
"Advance Rate with respect to Unitranche Loans"
The advance rate is the percentage of an asset’s appraised or stated value that a lender is willing to loan against, commonly used for receivables, inventory, or property. For investors it shows how much immediate cash a company can raise from its assets — like the share of value a pawnbroker will lend you — and affects liquidity, borrowing capacity and perceived credit risk.
Unitranche Loans financial
"Advance Rate with respect to Unitranche Loans"
Unitranche loans combine what would normally be two layers of lending — one that gets paid first and one that is paid later — into a single loan with one interest rate and one set of documents. Think of it as putting a mortgage and a second loan into one envelope: it simplifies and speeds up borrowing while usually carrying a higher interest rate to compensate for added risk. Investors care because unitranche debt changes the balance of risk and return, recovery prospects if a borrower defaults, and how easily the debt can be traded or refinanced.
Borrowing Base Value financial
"Borrowing Base Value of all Collateral Loans"
Aggregate ECA Value financial
"35.0% of Aggregate ECA Value"
Key Person technical
"amends the definition of “Key Person”"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Which banks act as agents under Saratoga Investment Corp. (SAJ)'s amended Valley Credit Facility?

Valley National Bank is the administrative agent. U.S. Bank Trust Company, National Association is the collateral agent and collateral administrator.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
false 0001377936 0001377936 2026-10-08 2026-10-08 0001377936 SAR:Commonstockparvalue0.001pershareMember 2026-10-08 2026-10-08 0001377936 SAR:Sec8.00NotesDue2027Member 2026-10-08 2026-10-08 0001377936 SAR:Sec8.125NotesDue2027Member 2026-10-08 2026-10-08 0001377936 SAR:Sec8.50NotesDue2028Member 2026-10-08 2026-10-08 0001377936 SAR:Sec7.50NotesDue2031Member 2026-10-08 2026-10-08 0001377936 SAR:Sec8.00NotesDue2031Member 2026-10-08 2026-10-08 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): October 8, 2026

 

 

 

SARATOGA INVESTMENT CORP.

(Exact Name of Registrant as Specified in Charter)

 

 

 

Maryland   814-00732   20-8700615
(State or Other Jurisdiction
of Incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)
   

 

535 Madison Avenue
New York, New York
  10022
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code (212) 906-7800

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.001 per share   SAR   New York Stock Exchange
8.00% Notes due 2027   SAJ   New York Stock Exchange
8.125% Notes due 2027   SAY   New York Stock Exchange
8.50% Notes due 2028   SAZ   New York Stock Exchange
7.50% Notes due 2031   SAV   New York Stock Exchange
8.00% Notes due 2031   SAX   New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company  ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 

 

 

 

Item 1.01. Entry into a Material Definitive Agreement.

 

On October 8, 2026, Saratoga Investment Corp. (the “Company”) and its wholly owned financing subsidiary, Saratoga Investment Funding II LLC (“SIF II” or the “Borrower”), entered into the First Amendment to the Credit and Security Agreement (the “Amendment” and as amended by the Amendment, the “Credit Agreement”), by and among SIF II, as borrower, the Company, as collateral manager and as equityholder, the lenders parties thereto, Valley National Bank, as administrative agent, and U.S. Bank Trust Company, National Association, as collateral agent, and collateral administrator (the “Valley Credit Facility”). The Amendment, among other things: (i) increases the borrowings available under the Valley Credit Facility from $85.0 million to $110.0 million; (ii) increases the amount whereby SIF II, during the first two years following the closing date, is permitted to request one or more increases in the commitment amount from $100.0 million to $135.0 million, subject to certain terms and conditions and a customary fee; (iii) provides that the Advance Rate (as defined in the Credit Agreement) with respect to Unitranche Loans (as defined in the Credit Agreement) will not exceed 70%; (iv) increases the aggregate amount by which the total of the Borrowing Base Value of all Collateral Loans may be concentrated in the healthcare industry from 25.0% to 35.0% of Aggregate ECA Value (each as defined in the Credit Agreement); (v) increases the aggregate amount by which the total of the Borrowing Base Value of all Collateral Loans which are made to the three largest Obligors (as defined in the Credit Agreement) from 30.0% to 35.0% of Aggregate ECA Value; and (vi) amends the definition of “Key Person” to replace Henri Steenkamp with Christine Ramdihal.

 

The foregoing description is only a summary of the material provisions of the Amendment and is qualified in its entirety by reference to a copy of the Amendment, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated by reference herein.

 

Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

 

The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.   Description
10.1   First Amendment to Credit and Security Agreement, dated as of October 8, 2026, by and among Saratoga Investment Funding II, LLC, as borrower, Saratoga Investment Corp., as collateral manager and equityholder, the lenders parties thereto, Valley National Bank, as administrative agent, and U.S. Bank Trust Company, National Association, as collateral agent, and collateral administrator.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

1

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  SARATOGA INVESTMENT CORP.
     
Date: October 9, 2026 By: /s/ Henri J. Steenkamp
  Name: Henri J. Steenkamp
  Title: Chief Financial Officer, Chief Compliance Officer, Treasurer and Secretary

 

2

 

Filing Exhibits & Attachments

5 documents

Keep reading